Literature DB >> 7302777

Evaluation of lorcainide, a new anti-arrhythmic agent.

E A Lloyd, L J Workman, P J Commerford, T A Mabin.   

Abstract

A new anti-arrhythmic agent, lorcainide, has been compared with lignocaine in patients with acute myocardial infarction. Lorcainide has been shown to be as effective as lignocaine in suppressing ventricular ectopy. Lorcainide is unusually free of side-effects and has the great advantage over lignocaine of being effective when given orally.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7302777

Source DB:  PubMed          Journal:  S Afr Med J


  1 in total

Review 1.  Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  C e Eiriksson; R N Brogden
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.